Archives
- 2018-07
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
-
In the present study DRD decreased in the
2019-07-30
In the present study, DRD3 decreased in the VTA of OA when compared with the control group.
-
Twin studies have shown that P has moderate heritability
2019-07-29
Twin studies have shown that P has moderate heritability. Zuckerman (1989) reviewed the earlier studies of P or related traits and found a median heritability of 0.51.
-
In LPS treated BV cells we found
2019-07-27
In LPS-treated BV-2 cells, we found that the upregulated CysLT2R was translocated into the nucleus. The nuclear localization of CysLT2Rs in microglia has not been reported previously.
-
br Conflict of interest br Supplementary
2019-07-26
Acknowledgments This work was supported by an Early Career Researcher grant awarded by the Institute of Health and Biomedical Innovation to IMW and Queensland University of Technology
-
Propranolol initially discovered in is first
2019-07-25
Propranolol, initially discovered in 1964, is first and most widely studied as a non-selective beta-blocker. Propranolol through β-adrenergic receptor blockade has reduced heart rate and blood pressure and have anti-arrhythmogenic and anti-ischemic effects
-
Based on both the observational and theoretical data generat
2019-07-24
Based on both the observational and theoretical data generated in this study, it appears that the mechanism(s) underlying lower IFM CPT1 activity is complex.
-
The field of synthetic cytokine biology continues to
2019-07-23
The field of synthetic cytokine biology continues to grow through molecular, physiological and pathophysiological insights, as well as via new methodical advances.
-
The regression also revealed a significant association
2019-07-22
The regression also revealed a significant association between admission selectivity (SELECT) and exam pass rate (PASS%) (p < .001) providing support for H4.
-
br Materials and methods br
2019-07-19
Materials and methods
-
DDI is one of the main problems
2019-07-18
DDI is one of the main problems with serious clinical consequences in clinical settings.
-
Recent pharmaceutical research in the field of respiratory
2019-07-17
Recent pharmaceutical research in the field of respiratory diseases has sought to make available new agents that specifically and selectively antagonize the actions of cysteinyl–leukotrienes.
-
Alpha SYN has no direct effect
2019-07-16
Alpha-SYN has no direct effect on forskolin-induced CREB phosphorylation, but rather blocks the stimulation of CRE-mediated transcription in the nucleus.
-
ACE also known as Kininase II
2019-07-15
ACE also known as Kininase II is an important enzyme of the Renin angiotensin XL228 system (RAAS) (Novo et al., 1987)
-
Furthermore our sample preparation uses
2019-07-13
Furthermore, our sample preparation uses a simple isolation procedure.
-
Hello world!
2018-07-29
14490 records 966/966 page Previous First page 上5页 966